JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2000; 35:563-568
© 2000 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mak, K.-H.
Right arrow Articles by Topol, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mak, K.-H.
Right arrow Articles by Topol, E. J.

Emerging concepts in the management of acute myocardial infarction in patients with diabetes mellitus

Koon-Hou Mak, MBBS* and Eric J. Topol, MD{dagger}

* Department of Cardiology, National Heart Centre, Singapore
{dagger} Department of Cardiology, Joseph J. Jacobs for Thrombosis and Vascular Biology, The Cleveland Clinic Foundation, Cleveland, Ohio, USA



View larger version (23K):

[in a new window]
 
Figure 1 Kaplan-Meier estimates of cumulative mortality by diabetes status in the GUSTO-I Study (3).

 


View larger version (17K):

[in a new window]
 
Figure 2 Odds ratio in a multiple logistic regression model for predicting the use of fibrinolysis in the SAVE Trial. SAVE = Survival and Ventricular Enlargement Study.

 


View larger version (17K):

[in a new window]
 
Figure 3 In-hospital angiographic reocclusion and 30-day reinfarction rates after fibrinolysis in the GUSTO-I Study.

 





HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2000 by the American College of Cardiology Foundation.